Goto

Collaborating Authors

 beno


BENO: Boundary-embedded Neural Operators for Elliptic PDEs

Wang, Haixin, Li, Jiaxin, Dwivedi, Anubhav, Hara, Kentaro, Wu, Tailin

arXiv.org Artificial Intelligence

Elliptic partial differential equations (PDEs) are a major class of time-independent PDEs that play a key role in many scientific and engineering domains such as fluid dynamics, plasma physics, and solid mechanics. Recently, neural operators have emerged as a promising technique to solve elliptic PDEs more efficiently by directly mapping the input to solutions. However, existing networks typically cannot handle complex geometries and inhomogeneous boundary values present in the real world. Here we introduce Boundary-Embedded Neural Operators (BENO), a novel neural operator architecture that embeds the complex geometries and inhomogeneous boundary values into the solving of elliptic PDEs. Inspired by classical Green's function, BENO consists of two branches of Graph Neural Networks (GNNs) for interior source term and boundary values, respectively. Furthermore, a Transformer encoder maps the global boundary geometry into a latent vector which influences each message passing layer of the GNNs. We test our model extensively in elliptic PDEs with various boundary conditions. We show that all existing baseline methods fail to learn the solution operator. In contrast, our model, endowed with boundary-embedded architecture, outperforms state-of-the-art neural operators and strong baselines by an average of 60.96\%. Our source code can be found https://github.com/AI4Science-WestlakeU/beno.git.


AI Takes Aim at Lung Cancer Screening

#artificialintelligence

WEDNESDAY, March 13, 2019 (HealthDay News) -- The term artificial intelligence (AI) might bring to mind robots or self-driving cars. But one group of researchers is using a type of AI to improve lung cancer screening. Screening is important for early diagnosis and improved survival odds, but the current lung cancer screening method has a 96 percent false positive rate. But in the new study, investigators were able to reduce false findings of lung cancer without missing any actual cases. A low-dose CT scan is the standard diagnostic test for people at high risk of lung cancer.